A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos Papadopoulos, Alejandro D. Ricart, E. Gabriella Chiorean, Robert S. Dipaola, Mark N. Stein, Caio M. Rocha Lima, James J. Schlesselman, Khaled Tolba, Virginia K. Langmuir, Stewart Kroll, Donald T. Jung, Metin Kurtoglu, Joseph Rosenblatt, Theodore J. Lampidis

Research output: Contribution to journalArticlepeer-review

237 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds